The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
Open accessAbstract
The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter- and intra-cellular communication, which regulates fundamental cell functions such as growth, survival, and differentiation. The MAPK pathway also integrates signals from complex intracellular networks in performing cellular functions. Despite the initial discovery of the core elements of the MAPK pathways nearly four decades ago, additional findings continue to make a thorough understanding of the molecular mechanisms involved in the regulation of this pathway challenging. Considerable effort has been focused on the regulation of RAF, especially after the discovery of drug resistance and paradoxical activation upon inhibitor binding to the kinase. RAF activity is regulated by phosphorylation and conformation-dependent regulation, including auto-inhibition and dimerization. In this review, we summarize the recent major findings in the study of the RAS/RAF/MEK/ERK signaling cascade, particularly with respect to the impact on clinical cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–315 of 315
Kato‐Stankiewicz, J., Hakimi, I., Zhi, G., Zhang, J., Serebriiskii, I. G., Guo, L., Edamatsu, H., Koide, H., Menon, S., Eckl, R. W., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222222699 · Cited by 143
Beck, T. W., Huleihel, M., Gunnell, M., Bonner, T. I., & Rapp, U. R. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.2.595 · Cited by 141
BRAF, a target in melanoma: Implications for solid tumor drug development
Flaherty, K. T., & McArthur, G. A. (2010) · Cancer · doi:10.1002/cncr.25261 · Cited by 139
Röring, M., Herr, R., Fiala, G. J., Heilmann, K., Braun, S. L., Eisenhardt, A. E., Halbach, S., Capper, D., von Deimling, A., Schamel, W. W. A., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.100 · Cited by 139
Regulation of Raf-1 and Raf-1 Mutants by Ras-Dependent and Ras-Independent Mechanisms In Vitro
Dent, P., Reardon, D. B., Morrison, D. K., & Sturgill, T. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4125 · Cited by 136
RAF Inhibitors Activate the MAPK Pathway by Relieving Inhibitory Autophosphorylation
Holderfield, M. T., Merritt, H., Chan, J., Wallroth, M., Tandeske, L., Zhai, H., Tellew, J. E., Hardy, S. F., Hekmat-Nejad, M., Stuart, D. D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.033 · Cited by 134
Norris, J. L., & Baldwin, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13841 · Cited by 133
Kinase Regulation by Hydrophobic Spine Assembly in Cancer
Hu, J., Ahuja, L. G., Meharena, H. S., Kannan, N., Kornev, A. P., Taylor, S. S., & Shaw, A. S. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00943-14 · Cited by 133
Self-citationHu, J., Yu, H., Kornev, A. P., Zhao, J., Filbert, E. L., Taylor, S. S., & Shaw, A. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102554108 · Cited by 133
Self-citationMolzan, M., Schumacher, B., Ottmann, C., Baljuls, A., Polzien, L., Weyand, M., Thiel, P., Rose, R., Rose, M., Kuhenne, P., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-09 · Cited by 131
Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells
Im, E., von Lintig, F. C., Chen, J. L., Zhuang, S., Qui, W., Chowdhury, S., Worley, P. F., Boss, G. R., & Pilz, R. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205792 · Cited by 130
KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis
Rabara, D., Tran, T. H., Dharmaiah, S., Stephens, R. M., McCormick, F., Simanshu, D. K., & Holderfield, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908353116 · Cited by 128
Seghers, A. C., Wilgenhof, S., Lebbé, C., & Neyns, B. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e3283541541 · Cited by 128
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Dephosphorylation of Ser-259 Regulates Raf-1 Membrane Association
Kubicek, M., Pacher, M., Abraham, D., Podar, K., Eulitz, M., & Baccarini, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108733200 · Cited by 124
Luo, Z., Diaz, B., Marshall, M. S., & Avruch, J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.46 · Cited by 123
Craf-1 protein kinase is essential for mouse development
Wojnowski, L., Stancato, L. F., Zimmer, A. M., Hahn, H., Beck, T. W., Larner, A. C., Rapp, U. R., & Zimmer, A. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00111-7 · Cited by 121
Lobell, R. B., Liu, D., Buser, C. A., Davide, J. P., DePuy, E., Hamilton, K., Koblan, K. S., Lee, Y., Mosser, S. D., Motzel, S. L., et al. (2002) · PubMed · Cited by 121
Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit
Ritt, D. A., Abreu‐Blanco, M. T., Bindu, L. K., Durrant, D., Zhou, M., Specht, S. I., Stephen, A. G., Holderfield, M. T., & Morrison, D. K. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.029 · Cited by 121
Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis
Wojnowski, L., Stancato, L. F., Larner, A. C., et al. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00276-2 · Cited by 120
Targeting the Mitogen-Activated Protein Kinase Pathway in the Treatment of Malignant Melanoma
Panka, D. J., Atkins, M. B., & Mier, J. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2539 · Cited by 120
Sanclemente, M., Francoz, S., Esteban-Burgos, L., Bousquet-Mur, E., Djurec, M., Lopez-Casas, P. P., Hidalgo, M., Guerra, C., Drosten, M., Musteanu, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.014 · Cited by 119
Quilliam, L. A., Castro, A. F., Rogers-Graham, K. S., Martin, C. B., Der, C. J., & Bi, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.23850 · Cited by 119
Thapar, R., Williams, J. G., & Campbell, S. L. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.106 · Cited by 118
Sjogren, A.-K. M., Andersson, K., Liu, M., Cutts, B. A., Karlsson, C., Wahlstrom, A. M., Dalin, M. G., Weinbaum, C., Casey, P. J., Tarkowski, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30868 · Cited by 118
A dynamic hydrophobic core orchestrates allostery in protein kinases
Kim, J., Ahuja, L. G., Chao, F.-A., Xia, Y., McClendon, C. L., Kornev, A. P., Taylor, S. S., & Veglia, G. (2017) · Science Advances · doi:10.1126/sciadv.1600663 · Cited by 118
Wang, M., Tan, W., Zhou, J., Leow, J., Go, M., Lee, H. S., & Casey, P. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801855200 · Cited by 116
Self-citationCharacterization of Murine A-raf, a New Oncogene Related to the v-raf Oncogene
Huleihel, M., Goldsborough, M. D., Cleveland, J. L., Gunnell, M., Bonner, T. I., & Rapp, U. R. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.7.2655-2662.1986 · Cited by 116
Identification of novel ERK-mediated feedback phosphorylation sites at the C-terminus of B-Raf
Brummer, T., Naegele, H., Reth, M. G., & Misawa, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1207185 · Cited by 115
Phosphorylation of Raf-1 by p21-activated Kinase 1 and Src Regulates Raf-1 Autoinhibition
Tran, N. H., & Frost, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210318200 · Cited by 115
Homologous cell-derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611
Jansen, H. W., Lurz, R., Bister, K., Bonner, T. I., Mark, G. E., & Rapp, U. R. (1984) · Nature · doi:10.1038/307281a0 · Cited by 115
Sun, Y., Alberta, J. A., Pilarz, C., Calligaris, D., Chadwick, E. J., Ramkissoon, S. H., Ramkissoon, L. A., Matía, V., Mazzola, E., Goumnerova, L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now261 · Cited by 113
Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region
Jang, H., Abraham, S. J., Chavan, T., Hitchinson, B., Khavrutskii, L., Tarasova, N. I., Nussinov, R., & Gaponenko, V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620724 · Cited by 112
Okaniwa, M., Hirose, M., Arita, T., Yabuki, M., Nakamura, A., Takagi, T., Kawamoto, T., Uchiyama, N., Sumita, A., Tsutsumi, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400778d · Cited by 112
Cdc37: a protein kinase chaperone?
Hunter, T., & Poon, R. Y. C. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01027-1 · Cited by 111
Buss, J. E., Quilliam, L. A., Kato, K., Casey, P. J., Solski, P. A., Wong, G., Clark, R., McCormick, F. P., Bokoch, G., & Der, C. J. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1523 · Cited by 111
Ras inhibition via direct Ras binding—is there a path forward?
Wang, W., Fang, G., & Rudolph, J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.082 · Cited by 109
Williams, J. G., Drugan, J. K., Yi, G. S., Clark, G. J., Der, C. J., & Campbell, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000397200 · Cited by 109
Specific function of B-Raf in mediating survival of embryonic motoneurons and sensory neurons
Wiese, S., Pei, G., Karch, C., Troppmair, J., Holtmann, B., Rapp, U. R., & Sendtner, M. (2001) · Nature Neuroscience · doi:10.1038/83960 · Cited by 108
Li, Z., Jiang, K., Zhu, X., Lin, G., Song, F., Zhao, Y., Piao, Y., Liu, J., Cheng, W., Bi, X., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.015 · Cited by 107
Raf-1 Addiction in Ras-Induced Skin Carcinogenesis
Ehrenreiter, K., Kern, F., Velamoor, V., Meissl, K., Galabova‐Kovacs, G., Sibilia, M. C., & Baccarini, M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.008 · Cited by 106
Mandal, A. K., Lee, P. C., Chen, J. A., Nillegoda, N. B., Heller, A., DiStasio, S., Oen, H. O., Victor, J., Nair, D. M., Brodsky, J. L., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200604106 · Cited by 105
RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
Jin, T., Lavoie, H., Sahmi, M., David, M., Hilt, C., Hammell, A., & Therrien, M. (2017) · Nature Communications · doi:10.1038/s41467-017-01274-0 · Cited by 101
Protein farnesyltransferase in embryogenesis, adult homeostasis, and tumor development
Mijimolle, N., Velasco, J. A., Dubus, P. R., Guerra, C. E., Weinbaum, C., Casey, P. J., Campuzano, V., & Barbacid, M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.004 · Cited by 100
CK2 Is a Component of the KSR1 Scaffold Complex that Contributes to Raf Kinase Activation
Ritt, D. A., Zhou, M., Conrads, T. P., Veenstra, T. D., Copeland, T. D., & Morrison, D. K. (2006) · Current Biology · doi:10.1016/j.cub.2006.11.061 · Cited by 100
Noeparast, A., Teugels, E., Giron, P., Verschelden, G., Brakeleer, S. D., Decoster, L., & Grève, J. D. (2016) · Oncotarget · doi:10.18632/oncotarget.11635 · Cited by 98
RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation
Saha, M., Carriere, A., Cheerathodi, M., Zhang, X., Lavoie, G., Rush, A. J., Roux, P. P., & Ballif, B. A. (2012) · Biochemical Journal · doi:10.1042/bj20120938 · Cited by 94
Inactivating Icmt ameliorates K-RAS–induced myeloproliferative disease
Wahlstrom, A. M., Cutts, B. A., Liu, M., Lindskog, A., Karlsson, C., Sjogren, A.-K. M., Andersson, K., Young, S. G., & Bergö, M. O. (2008) · Blood · doi:10.1182/blood-2007-06-094060 · Cited by 93
Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner
Cleghon, V., & Morrison, D. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32504-8 · Cited by 91
B- and C-RAF Display Essential Differences in Their Binding to Ras
Fischer, A., Hekman, M., Kuhlmann, J., Rubio, I., Wiese, S., & Rapp, U. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607458200 · Cited by 91
Fiordalisi, J. J., Johnson, R. L., Weinbaum, C., Sakabe, K., Chen, Z., Casey, P. J., & Cox, A. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305733200 · Cited by 90
Smyth, T., Paraiso, K. H. T., Hearn, K., Rodríguez-López, A. M., Munck, J. M., Haarberg, H. E., Sondak, V. K., Thompson, N. T., Azab, M., Lyons, J. F., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0452 · Cited by 89
Alavi, A., Acevedo, L. M., Wang, M., & Cheresh, D. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3648 · Cited by 88
Self-citationRauch, J., O’Neill, E. E., Mack, B., Matthias, C., Münz, M., Kölch, W., & Gires, O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2740 · Cited by 85
Raf-1 Antagonizes Erythroid Differentiation by Restraining Caspase Activation
Kolbus, A., Pilat, S., Husak, Z., Deiner, E. M., Stengl, G., Beug, H., & Baccarini, M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020562 · Cited by 85
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling
Piazzolla, D., Meissl, K., Kučerová, L., Rubiolo, C., & Baccarini, M. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504137 · Cited by 85
Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain
Travers, T. S., López, C. A., Van, Q. N., Neale, C., Tonelli, M., Stephen, A. G., & Gnanakaran, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-26832-4 · Cited by 82
The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner.
Xia, K., Mukhopadhyay, N. K., Inhorn, R. C., Barber, D. L., Rose, P., Lee, R. S., Narsimhan, R. P., D’Andrea, A. D., Griffin, J. D., & Roberts, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11681 · Cited by 79
Ikenoue, T., Hikiba, Y., Kanai, F., Aragaki, J., Tanaka, Y., Imamura, J., Imamura, T., Ohta, M., Ijichi, H., Tateishi, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3591 · Cited by 77
The RAS–Effector Interaction as a Drug Target
Keeton, A. B., Salter, E. A., & Piazza, G. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0938 · Cited by 77
Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.
Papin, C., DENOUEL, A., Calothy, G., & Eychène, A. (1996) · PubMed · Cited by 76
Wang, M., Hossain, M. S., Tan, W., Coolman, B., Zhou, J., Liu, S., & Casey, P. J. (2010) · Oncogene · doi:10.1038/onc.2010.247 · Cited by 75
Self-citationClark, G. J., Drugan, J. K., Terrell, R. S., Bradham, C. A., Der, C. J., Bell, R. M., & Campbell, S. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1577 · Cited by 75
S338 Phosphorylation of Raf-1 Is Independent of Phosphatidylinositol 3-Kinase and Pak3
Chiloeches, A., Mason, C., & Marais, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.7.2423-2434.2001 · Cited by 75
Peterson, Y. K., Kelly, P., Weinbaum, C., & Casey, P. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600168200 · Cited by 74
Jain, P., Fierst, T. M., Han, H. J., Smith, T. L., Vakil, A., Storm, P. B., Resnick, A. C., & Waanders, A. J. (2017) · Oncogene · doi:10.1038/onc.2017.276 · Cited by 72
Andreadi, C., Cheung, L.-K. M., Giblett, S. M., PATEL, B., Jin, H., Mercer, K., Kamata, T., Lee, P., Williams, A. G., McMahon, M., et al. (2012) · Genes & Development · doi:10.1101/gad.193458.112 · Cited by 68
Negative regulation of mitochondrial VDAC channels by C-Raf kinase
Mellay, V. L., Troppmair, J., Benz, R., & Rapp, U. R. (2002) · BMC Cell Biology · doi:10.1186/1471-2121-3-14 · Cited by 65
Discrete cytosolic macromolecular BRAF complexes exhibit distinct activities and composition
Diedrich, B., Rigbolt, K. T. G., Röring, M., Herr, R., Kaeser-Pebernard, S., Gretzmeier, C., Murphy, R. F., Brummer, T., & Dengjel, J. (2017) · The EMBO Journal · doi:10.15252/embj.201694732 · Cited by 64
Lau, H. Y., Ramanujulu, P. M., Guo, D., Yang, T., Wirawan, M., Casey, P. J., Go, M., & Wang, M. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.29692 · Cited by 63
Self-citationActivating mutations in MEK1 enhance homodimerization and promote tumorigenesis
Yuan, J., Ng, W. H., Tian, Z., Yap, J., Baccarini, M., Chen, Z., & Hu, J. (2018) · Science Signaling · doi:10.1126/scisignal.aar6795 · Cited by 63
Self-citationIdentification of Raf‐1 Ser621 kinase activity from NIH 3T3 cells as AMP‐activated protein kinase
Sprenkle, A. B., Davies, S. P., Carling, D., Hardie, D. G., & Sturgill, T. W. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00062-8 · Cited by 59
A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation
Rubiolo, C., Piazzolla, D., Meissl, K., Beug, H., Huber, J. C., Kolbus, A., & Baccarini, M. (2006) · Blood · doi:10.1182/blood-2005-09-3866 · Cited by 59
Tutuka, C. S. A., Andrews, M. C., Mariadason, J. M., Ioannidis, P., Hudson, C., Cebon, J., & Behren, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0684-x · Cited by 58
Scheffler, J. E., Waugh, D. S., Bekesi, E., Kiefer, S. E., LoSardo, J. E., Neri, A., Prinzo, K., Tsao, K. L., Wegrzynski, B. B., & Emerson, S. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31795-7 · Cited by 58
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma
Williams, T. E., Subramanian, S., Verhagen, J., McBride, C. M., Costales, A., Sung, L., Antonios-McCrea, W., McKenna, M., Louie, A. K., Ramurthy, S., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500526p · Cited by 57
Yuan, J., Ng, W. H., Lam, P. Y. P., Wang, Y., Xia, H., Yap, J., Guan, S. P., Lee, A. S. G., Wang, M., Baccarini, M., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0365-2 · Cited by 57
Self-citationManu, K. A., Chai, T. F., Teh, J. T., Zhu, W. L., Casey, P. J., & Wang, M. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0703 · Cited by 55
Self-citationWinkler, D. G., Cutler, R. E., Drugan, J. K., Campbell, S. L., Morrison, D. K., & Cooper, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21578 · Cited by 54
Fluoride complexes of oncogenic Ras mutants to study the Ras-RasGAP interaction
Gremer, L., Gilsbach, B. K., Ahmadian, M. R., & Wittinghofer, A. (2008) · Biological Chemistry · doi:10.1515/bc.2008.132 · Cited by 54
Douziech, M., Sahmi, M., Laberge, G., & Therrien, M. (2006) · Genes & Development · doi:10.1101/gad.1390406 · Cited by 54
The C-terminus of Raf-1 acts as a 14-3-3-dependent activation switch
Dhillon, A. S., Yip, Y. Y., Grindlay, G. J., Pakay, J. L., Dangers, M., Hillmann, M., Clark, W. A., Pitt, A. R., Mischak, H., & Kölch, W. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.07.001 · Cited by 52
Niault, T., Sobczak, I., Meissl, K., Weitsman, G. E., Piazzolla, D., Maurer, G., Kern, F., Ehrenreiter, K., Hamerl, M., Moarefi, I., et al. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200906178 · Cited by 52
Phosphorylation of RAF Kinase Dimers Drives Conformational Changes that Facilitate Transactivation
Jambrina, P. G., Rauch, N., Pilkington, R., Rybakova, K. N., Nguyen, L. K., Kholodenko, B. Ν., Buchete, N., Kölch, W., & Rosta, E. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201509272 · Cited by 49
Troppmair, J., Hartkamp, J., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201981 · Cited by 48
Regulation of glycolysis by Raf protein serine/threonine kinases
Mellay, V. L., Houben, R., Troppmair, J., Hagemann, C., Mazurek, S., Frey, U. H., Beigel, J., Weber, C. K., Benz, R., EIGENBRODT, E., et al. (2002) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(01)00036-x · Cited by 46
A new oncogene, c-raf, is located on mouse chromosome 6
Kozak, C. A., Gunnell, M., & Rapp, U. R. (1984) · Journal of Virology · doi:10.1128/jvi.49.1.297-299.1984 · Cited by 44
Baljuls, A., Schmitz, W., Mueller, T. D., Zahedi, R. P., Sickmann, A., Hekman, M., & Rapp, U. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801782200 · Cited by 43
Pseudokinases from a structural perspective
Taylor, S. S., Shaw, A. S., Hu, J., Meharena, H. S., & Kornev, A. P. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130120 · Cited by 43
Self-citationRamurthy, S., Taft, B. R., Aversa, R. J., Barsanti, P. A., Burger, M. T., Lou, Y. C., Nishiguchi, G., Rico, A. C., Setti, L., Smith, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00161 · Cited by 43
Generation of New Mouse Sarcoma Viruses in Cell Culture
Rapp, U. R., & Todaro, G. J. (1978) · Science · doi:10.1126/science.210501 · Cited by 42
Activation loop phosphorylation regulates B‐Raf in vivo and transformation by B‐Raf mutants
Köhler, M., Röring, M., Schorch, B., Heilmann, K., Stickel, N., Fiala, G. J., Schmitt, L. C., Braun, S. L., Ehrenfeld, S., Uhl, F. M., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201592097 · Cited by 42
Bergman, J. A., Hahne, K., Jiao, S., Hrycyna, C. A., & Gibbs, R. A. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200106d · Cited by 41
B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.
Papin, C., Eychène, A., Brunet, A., Pagès, G., Pouysségur, J., Calothy, G., & Barnier, J. (1995) · PubMed · Cited by 41
Salzano, M., Rusciano, M. R., Russo, E., Bifulco, M., Postiglione, L., & Vitale, M. (2012) · Cell Cycle · doi:10.4161/cc.20543 · Cited by 37
Mercer, K., Giblett, S. M., Oakden, A., Brown, J., Marais, R., & Pritchard, C. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208707 · Cited by 37
Thompson, P. A., Ledbetter, J. A., Rapp, U. R., & Bolen, J. B. (1991) · PubMed · Cited by 36
RAS Mutations Are Not Created Equal
Hobbs, G. A., & Der, C. J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0406 · Cited by 35
Teh, J. T., Zhu, W., Ilkayeva, O., Li, Y., Gooding, J. R., Casey, P. J., Summers, S. A., Newgard, C. B., & Wang, M. (2014) · Oncogene · doi:10.1038/onc.2014.260 · Cited by 33
Self-citationPhospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles
Eisenhardt, A. E., Sprenger, A., Röring, M., Herr, R., Weinberg, F., Köhler, M., Braun, S. L., Orth, J. H. C., Diedrich, B., Lanner, U., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8427 · Cited by 31
H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis
Millán, O., Ballester, A., Castrillo, A., Oliva, J. L., Través, P. G., Rojas, J. M., & Boscá, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206179 · Cited by 28
Drosten, M., Simón-Carrasco, L., Hernández-Porras, I., Lechuga, C. G., Blasco, M. T., Jacob, H. K. C., Fabbiano, S., Potenza, N., Bustelo, X. R., Guerra, C. E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-2925 · Cited by 28
Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain
Tassin, T. C., Benavides, D. R., Plattner, F., Nishi, A., & Bibb, J. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.654897 · Cited by 23
B-Raf activation loop phosphorylation revisited
Köhler, M., & Brummer, T. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1159111 · Cited by 23
Kwong, L. N., & Chin, L. (2010) · Cell · doi:10.1016/j.cell.2010.01.013 · Cited by 20
Synthetic lethality: emerging targets and opportunities in melanoma
Thompson, N., Adams, D. J., & Ranzani, M. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12573 · Cited by 20
Yuan, J., Ng, W. H., Yap, J., Chia, B., Huang, X., Wang, M., & Hu, J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004597 · Cited by 20
Self-citationRaf-1 and B-Raf promote protein kinase C θ interaction with BAD
Hindley, A. D., & Kölch, W. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.08.004 · Cited by 19
A new signaling paradigm to control the prenylation and trafficking of small GTPases
Williams, C. L. (2013) · Cell Cycle · doi:10.4161/cc.26230 · Cited by 19
A patent review of BRAF inhibitors: 2013-2018
Wang, P., Qiu, H., & Zhu, H. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2019.1640680 · Cited by 11
Christensen, J. G., Fell, J. B., Marx, M. A., Fischer, J., Hallin, J. F., Calinisan, A., Baer, B. R., Burkhard, M. R., Blake, J. F., Vigers, G. P. A., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-lb-271 · Cited by 7
Yap, J., Yuan, J., Tee, Z. H., Huang, X., Ng, W. H., & Hu, J. (2019) · Journal of Visualized Experiments · doi:10.3791/59795 · Cited by 6
Self-citationSaturno, G., Lopes, F., Girotti, M. R., Niculescu‐Duvaz, I., Niculescu‐Duvaz, D., Zambon, A., Davies, L. C., Johnson, L., Preece, N., Virós, A., et al. (2016) · European Journal of Cancer · doi:10.1016/s0959-8049(16)61703-3 · Cited by 5
Ding, J., Tchaicheeyan, O., & Ambrosio, L. (2009) · Genetics · doi:10.1534/genetics.109.111344 · Cited by 4
Varga, A., & Baccarini, M. (2015) · The EMBO Journal · doi:10.15252/embj.201593566 · Cited by 3
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
Yuan, J., Dong, X., Yap, J., & Hu, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00949-4 · Cited by 493
Self-citationLipid metabolism in cancer progression and therapeutic strategies
Fu, Y., Zou, T., Shen, X., Nelson, P. J., Li, J., Wu, C., Yang, J., Zheng, Y., Bruns, C., Zhao, Y., et al. (2021) · MedComm · doi:10.1002/mco2.27 · Cited by 393
Romani, A. M. P. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115323 · Cited by 383
Sugiura, R., Satoh, R., & Takasaki, T. (2021) · Cells · doi:10.3390/cells10102509 · Cited by 369
Metadata
- Authors
- Degirmenci, U., Wang, M., & Hu, J.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-01-13
- Volume
- 9
- Issue
- 1
- Pages
- 198
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3000124456
- Cited by
- 534
- References
- 315
- FWCI
- 22.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.